Nothing to write home about. Just another analyst's view on all known issues. I nearly quit reading when reached a part where it said: Oral Copaxone (laquinimod). Besides, I don't think analysts can have any better idea about what will happen with Teva or Momenta. It's almost entirely in the hands of the FDA and the Court.
News 
Market Data 
Discover 
AI
